Exact Mass: 492.204
Exact Mass Matches: 492.204
Found 286 metabolites which its exact mass value is equals to given mass value 492.204
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Isolariciresinol 9'-O-alpha-L-arabinofuranoside
Isolariciresinol 9-O-alpha-L-arabinofuranoside is a constituent of Scots pine (Pinus sylvestris) needles. Constituent of Scots pine (Pinus sylvestris) needles.
4-[2-[2-[3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid
cis-2,3-Dihydro-2-(4-alpha-L-rhamnopyranosyloxy-3-methoxyphenyl)-3-hydroxymethyl-7-hydroxy-5-benzofuranpropanol
(+)-Isolariciresinol 2a-O-alpha-L-arabinopyranoside
4-{2-[[3-(4-hydroxy-3-methoxyphenyl)-2-propenyl]oxy]ethyl}-2-methoxyphenyl-beta-D-glucopyranoside
2,3-dihydro-7-methoxy-2-(4-hydroxy-3-methoxyphenyl)-3a-O-beta-D-xylopyranosyloxymethyl-5-benzofuranpropanol|9-O-beta-D-xylopyranoside vladinol F|dihydrodehydrodiconiferyl alcohol 9-O-beta-D-xylopyranoside
2,3-dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3a-alpha-L-rhamnopyranosyloxymethyl-5-benzofuranpropanol|Massonianoside A
(7S,8R)-3-demethoxydihydrodehydrodiconiferyl alcohol 4-O-beta-D-glucopyranoside|3-methoxyisocupressoside B
3-methoxy-3,4,9,9-tetrahydroxy-4,7-epoxy-5,8-lignan-3-O-alpha-L-rhamnopyranoside|juniperoside A
(7R,8S)-dihydrodehydrodiconiferyl alcohol 4-beta-D-xyloside
(8R)-isodehydrodiconiferyl alcohol-4-beta-D-xylopyranoside|acutumoside
2-{1-[(2R,3S)-2,3-dihydro-3-hydroxymethyl-5-(3-hydroxypropyl)-7-methoxy-2-benzofuranyl]-3,5-dimethoxy-4-phenoxy}-3-hydroxypropanoic acid methyl ester|dunnianeolignan A
13-O-beta-D-glucopyranosyl-gibberellin A5|GA5-13-O-glucoside
(5S)-1-((4-hydroxyphenyl)-7-(3,4-dihydroxyphenyl)-5-O-beta?D-glucopyranosyl)heptan-3-one
(2R*,3S*,4R*,6R*,7R*,8R*,10R*,11R*,14S*)-3-(2,3-epoxy-2-methylbutanoyloxy)-9-hydroxy-14-(3-hydroxy-3-methylbutanoyloxy)-14,15-epoxytrix-5(15)-en-4,12-olide
8-Ethyl-3-(3-formamidosalicylamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate
Enalapril maleate
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-ethyl-4-[(Z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
(2R,3S,4S,5S,6R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]-6-methyloxane-3,4,5-triol
(2R,3S,4S,5S,6R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]-6-methyloxane-3,4,5-triol_major
Ala Glu His His
Ala His Glu His
Ala His His Glu
Cys Asp Lys Gln
Cys Asp Gln Lys
Cys Glu Lys Asn
Cys Glu Asn Lys
Cys Lys Asp Gln
Cys Lys Glu Asn
Cys Lys Asn Glu
Cys Lys Gln Asp
Cys Asn Glu Lys
Cys Asn Lys Glu
Cys Asn Arg Thr
Cys Asn Thr Arg
Cys Gln Asp Lys
Cys Gln Lys Asp
Cys Gln Arg Ser
Cys Gln Ser Arg
Cys Arg Asn Thr
Cys Arg Gln Ser
Cys Arg Ser Gln
Cys Arg Thr Asn
Cys Ser Gln Arg
Cys Ser Arg Gln
Cys Thr Asn Arg
Cys Thr Arg Asn
Asp Cys Lys Gln
Asp Cys Gln Lys
Asp Lys Cys Gln
Asp Lys Gln Cys
Asp Gln Cys Lys
Asp Gln Lys Cys
Glu Ala His His
Glu Cys Lys Asn
Glu Cys Asn Lys
Glu His Ala His
Glu His His Ala
Glu Lys Cys Asn
Glu Lys Asn Cys
Glu Asn Cys Lys
Glu Asn Lys Cys
His Ala Glu His
His Ala His Glu
His Glu Ala His
His Glu His Ala
His His Ala Glu
His His Glu Ala
His Ser Ser Tyr
His Ser Tyr Ser
His Tyr Ser Ser
Lys Cys Asp Gln
Lys Cys Glu Asn
Lys Cys Asn Glu
Lys Cys Gln Asp
Lys Asp Cys Gln
Lys Asp Gln Cys
Lys Glu Cys Asn
Lys Glu Asn Cys
Lys Asn Cys Glu
Lys Asn Glu Cys
Lys Gln Cys Asp
Lys Gln Asp Cys
Met Asn Gln Thr
Met Asn Thr Gln
Met Gln Asn Thr
Met Gln Gln Ser
Met Gln Ser Gln
Met Gln Thr Asn
Met Ser Gln Gln
Met Thr Asn Gln
Met Thr Gln Asn
Asn Cys Glu Lys
Asn Cys Lys Glu
Asn Cys Arg Thr
Asn Cys Thr Arg
Asn Glu Cys Lys
Asn Glu Lys Cys
Asn Lys Cys Glu
Asn Lys Glu Cys
Asn Met Gln Thr
Asn Met Thr Gln
Asn Gln Met Thr
Asn Gln Thr Met
Asn Arg Cys Thr
Asn Arg Thr Cys
Asn Ser Ser Trp
Asn Ser Trp Ser
Asn Thr Cys Arg
Asn Thr Met Gln
Asn Thr Gln Met
Asn Thr Arg Cys
Asn Trp Ser Ser
Gln Cys Asp Lys
Gln Cys Lys Asp
Gln Cys Arg Ser
Gln Cys Ser Arg
Gln Asp Cys Lys
Gln Asp Lys Cys
Gln Lys Cys Asp
Gln Lys Asp Cys
Gln Met Asn Thr
Gln Met Gln Ser
Gln Met Ser Gln
Gln Met Thr Asn
Gln Asn Met Thr
Gln Asn Thr Met
Gln Gln Met Ser
Gln Gln Ser Met
Gln Arg Cys Ser
Gln Arg Ser Cys
Gln Ser Cys Arg
Gln Ser Met Gln
Gln Ser Gln Met
Gln Ser Arg Cys
Gln Thr Met Asn
Gln Thr Asn Met
Arg Cys Asn Thr
Arg Cys Gln Ser
Arg Cys Ser Gln
Arg Cys Thr Asn
Arg Asn Cys Thr
Arg Asn Thr Cys
Arg Gln Cys Ser
Arg Gln Ser Cys
Arg Ser Cys Gln
Arg Ser Gln Cys
Arg Thr Cys Asn
Arg Thr Asn Cys
Ser Cys Gln Arg
Ser Cys Arg Gln
Ser His Ser Tyr
Ser His Tyr Ser
Ser Met Gln Gln
Ser Asn Ser Trp
Ser Asn Trp Ser
Ser Gln Cys Arg
Ser Gln Met Gln
Ser Gln Gln Met
Ser Gln Arg Cys
Ser Arg Cys Gln
Ser Arg Gln Cys
Ser Ser His Tyr
Ser Ser Asn Trp
Ser Ser Trp Asn
Ser Ser Tyr His
Ser Trp Asn Ser
Ser Trp Ser Asn
Ser Tyr His Ser
Ser Tyr Ser His
Thr Cys Asn Arg
Thr Cys Arg Asn
Thr Met Asn Gln
Thr Met Gln Asn
Thr Asn Cys Arg
Thr Asn Met Gln
Thr Asn Gln Met
Thr Asn Arg Cys
Thr Gln Met Asn
Thr Gln Asn Met
Thr Arg Cys Asn
Thr Arg Asn Cys
Trp Asn Ser Ser
Trp Ser Asn Ser
Trp Ser Ser Asn
Tyr His Ser Ser
Tyr Ser His Ser
Tyr Ser Ser His
Isolariciresinol 9'-O-a-L-arabinofuranoside
[6-(2,6-dimethylnaphthalene-1-carbonyl)naphthalen-2-yl]-(2,6-dimethylnaphthalen-1-yl)methanone
Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside
(S)-1-((S)-2-(((R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid compound with maleic acid (1:1)
[3-chloro-4-(4-pentylbenzoyl)oxyphenyl] 4-pentylbenzoate
5-[1-(2,5-dimethylphenyl)sulfonyl-4-piperidinyl]-3-[(4-methylphenyl)methyl]-2H-triazolo[4,5-d]pyrimidin-7-one
8-[[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]methyl]-3-methyl-7-(2-phenylethyl)purine-2,6-dione
(4Z)-2,8:7,12:11,15:14,18:17,22-pentaanhydro-1,3-O-(2-carboxyethylidene)-4,5,6,9,10,13,19,20,21-nonadeoxy-L-arabino-L-allo-L-allo-docosa-4,9,20-trienitol
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-7-pyridin-3-yl-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-6-oxo-7-pyrimidin-5-yl-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-7-(3-pyridinyl)-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(1S,9R,10R,11R)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-12-methyl-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-12-methyl-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
9-(3,4-dimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-6,7,8a,9-tetrahydro-5H-[1,2,4]triazolo[5,1-b]quinazolin-8-one
2-Ethyl-4-[(z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
(1r,3s,4s,5s,7r,8s)-7,8-dihydroxy-7-[(1s)-1-hydroxyethyl]-3-[(1e,3e,5e)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trien-1-yl]-1,5-dimethyl-2,6-dioxabicyclo[3.2.1]octan-4-yl acetate
(2s,3s,4s,5s)-2-{[(2r,3r,4s)-6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}oxane-3,4,5-triol
(2s,3r,4r,5r,6s)-2-{4-[(2s,3r)-7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy}-6-methyloxane-3,4,5-triol
methyl (3as,4s,5s,11ar)-4-{[(2s)-2-hydroxy-2-methyl-3-oxobutanoyl]oxy}-10-methyl-3-methylidene-5-[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
2-(furan-3-yl)-6a,10b-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,7h,10ah-naphtho[2,1-c]pyran-4,10-dione
alboside iii
{"Ingredient_id": "HBIN015089","Ingredient_name": "alboside iii","Alias": "NA","Ingredient_formula": "C25H32O10","Ingredient_Smile": "CC1C(CC2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)OC(=O)C=CC4=CC=C(C=C4)OC)O","Ingredient_weight": "492.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "869","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100982917","DrugBank_id": "NA"}